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Background: Somatic cell nuclear transfer (SCNT) is currently the most efficient and precise method to generate
genetically tailored pig models for biomedical research. However, the efficiency of this approach is crucially
dependent on the source of nuclear donor cells. In this study, we evaluate the potential of primary porcine kidney
cells (PKCs) as cell source for SCNT, including their proliferation capacity, transfection efficiency, and capacity to
support full term development of SCNT embryos after additive gene transfer or homologous recombination.
Results: PKCs could be maintained in culture with stable karyotype for up to 71 passages, whereas porcine fetal
fibroblasts (PFFs) and porcine ear fibroblasts (PEFs) could be hardly passaged more than 20 times. Compared with
PFFs and PEFs, PKCs exhibited a higher proliferation rate and resulted in a 2-fold higher blastocyst rate after SCNT
and in vitro cultivation. Among the four transfection methods tested with a GFP expression plasmid, best results
were obtained with the NucleofectorTM technology, resulting in transfection efficiencies of 70% to 89% with high
fluorescence intensity, low cytotoxicity, good cell proliferation, and almost no morphological signs of cell stress.
Usage of genetically modified PKCs in SCNT resulted in approximately 150 piglets carrying at least one of 18
different transgenes. Several of those pigs originated from PKCs that underwent homologous recombination and
antibiotic selection before SCNT.
Conclusion: The high proliferation capacity of PKCs facilitates the introduction of precise and complex genetic
modifications in vitro. PKCs are thus a valuable cell source for the generation of porcine biomedical models by
SCNT.
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Over the last years the pig is getting more and more at-
tractive as model organism for biomedical research due
to similarities with humans in anatomy, size, physiology,
metabolism and pathology (reviewed in [1]). Early sexual
maturity and large litter sizes make pigs more suitable
for research than other larger animals like cow, sheep or
dog (reviewed in [2]). Furthermore, genetically engi-
neered pigs are a promising source of cells, tissues and
organs for xenotransplantation (reviewed in [3]).
Genetic modification of pigs can be achieved by a variety
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reproduction in any medium, provided the orDNA, sperm-mediated gene transfer, retroviral transduc-
tion, and somatic cell nuclear transfer (SCNT) using trans-
fected donor cells (reviewed in [4,5]). Due to the lack of
germ line competent pluripotent stem cells in pigs, the lat-
ter approach is currently the only route for the generation
of gene targeted pigs [6-8]. In addition, SCNT using pools
of stable transfected cell clones was an efficient way for
the production of transgenic founder pigs with appropriate
expression patterns (reviewed in [1,9]) and facilitated the
generation of the first pig models with inducible transgene
expression [10].
Among the various parameters influencing the outcome
of SCNT, such as oocyte quality, nuclear transfer proto-
col, embryo culture or recipient animal preparation, the
type and quality of the nuclear donor cells are of vital
importance (reviewed in [11]).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Single cell clone colonies of PKCm at P3. Single cell
colonies were generated and analyzed after 7 days. The cells and
formed colonies differed morphologically: fibroblast-like cells
[A, B, D-F, H], epithelial- and endothelial-like cells [C, G], cell size
(large [B], smaller [A, C-H]), colony compactness (cells very close
[A, E, G], gaps between cells [B, C, D, F, H]) and colony shape
(clearly defined [A, C, E, G], frayed colonies [B, D, F, H]).
Scale bar = 100 μm.
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primary culture were used for SCNT in pigs, with differ-
ences regarding the cell type, source organ, age and gender
of the donor animal. Among these cells, mesenchymal stem
cells are more or less precisely characterized [12,13].
Fibroblast-like cells from fetuses, neonatal, juvenile or adult
animals [14-16] or unspecified cells from different organs
[17,18] are most widely used. These cells have been tested
for their efficiency in SCNT experiments, but further
characterization of the specific cell types, their morphology,
proliferation, lifespan and stability of karyotype is mostly
lacking. The latter parameters are particularly important
for advanced genetic modification technologies such as
gene targeting, where transfected cells need to undergo
homologous recombination, clonal selection and prolifera-
tion up to a scale that provides a sufficient number of cells
for recombination analysis, cryopreservation and subse-
quent SCNT experiments. The efficiency of genetic modifi-
cation of primary cells also depends on the effective
introduction of DNA vectors into the cells. Different meth-
ods for the transfection of primary mammalian cells have
been described, including chemical (calcium phosphate
precipitation [19], lipofection [20], nanofection [21]) and
physical methods (electroporation [22], nucleofection [23],
microinjection [24]) as well as viral transduction [25], but
their applicability depends on the cell type into which the
DNA has to be introduced.
Here, we characterize for the first time primary kidney
cells (PKCs) isolated from kidney samples of juvenile
pigs for their proliferation capacity, morphological ap-
pearance, stability of karyotype, and uptake of exogenous
DNA after application of different transfection methods.
Furthermore, we show their potential to support devel-
opment of SCNT embryos in vitro and of viable genetic-
ally modified pigs after additive gene transfer and
homologous recombination.
Results
Morphology and growth potential of PKCs compared to
fibroblasts of different origin
Initial morphologic characterization of cells was per-
formed 24 h after isolation by bright field microscopy.
The cultures were usually 70–100% confluent and dis-
played a mixture of different cell morphologies. To
characterize PKC diversity, the two kidney cell lines
PKCm and PKC2109 were subcloned by generation of
single cell clones at passage 3 and their morphology was
evaluated 5 to 8 days later (Figure 1 and Additional file
1). The cell clones differed in morphology (fibroblast- or
epithelial cell-like), cell size, colony formation (clearly
defined or frayed), colony compactness (cell-to-cell dis-
tance), growth rate and lifespan.
In parallel, we investigated porcine fetal fibroblasts
(PFFs) and ear fibroblasts (PEFs) which also displayedmorphological heterogeneity, though to a lesser extent
than PKCs. In the primary cell lines PKCm, PKC2109,
PFF26 and PEF0110, the heterogeneous appearance
diminished with increasing passage numbers and the
culture became dominated by cells with spindle shaped
fibroblast-like morphology (Figure 2).
In a pilot experiment, PKCs seeded on non-coated cell
culture plates did not get properly confluent and rather
grew in islands. In contrast, on collagen-coated plates
Figure 2 Morphology of different primary pig cell lines after
several passages. Porcine kidney cells (PKCm and PKC2109), fetal
fibroblasts (PFF26) and ear fibroblasts (PEF0110) showed all a more
or less heterogeneous composition. In all primary cell lines the
morphology changed from smaller and round-shaped in early
passage (P2) to larger and long spindle-shaped cells in later passage
(P13). Scale bar = 100 μm.
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(Figure 3A PKCm, B PKC2109). For systematic investi-
gation of the growth behavior of PKCs on different coat-
ings, the proliferation of the primary cell lines PKCm
and PKC2109 was determined 48 h after seeding of dif-
ferent cell numbers (2,000, 5,000, or 10,000 cells per
well) on gelatin-, collagen- or non-coated 96-well culture
plates using an MTT based proliferation assay
(Figure 3A and B right diagram). The collagen-coated
plates notably promoted proliferation of the cells of both
kidney cell lines, as well as PFF and PEF cells (data notshown). Therefore, all further culture experiments were
performed in collagen-coated dishes.
Growth behavior and population doubling time of
PKCm and PKC2109 was determined and compared to
PFF26 and PEF0110 at passage 4–5. Growth curves were
generated and population doubling time was calculated in
the log phase (Figure 3C). After seeding, PKCm and in
particular PKC2109 cells started earlier to proliferate and
showed a steeper growth curve than PFF26 and PEF0110
cells. In the exponential growth phase, between 36 and
60 h after seeding (marked by an x in Figure 3C), the kid-
ney cell lines exhibited the shortest population doubling
time with 15.2 h (PKC2109) and 16.6 h (PKCm), followed
by PFF26 (23.2 h) and PEF0110 (32.9 h).
In a long-term culture experiment, kidney cells were
maintained for a high number of passages ‐ PKC2109
cells at least up to passage 71 and PKCm up to passage
50 ‐ showing only slight signs of senescence, whereas
PFF and PEF could hardly be passaged more than
20 times. Karyotype analysis (Figure 3D) revealed 80%
normal chromosome counts in PKCm at passage 3 and
74% in PKC2109 at passage 71, which was similar to the
proportion of normal karyotypes in PFF26 (68%) and
PEF0110 (75%) determined at passage 13. Due to the
fact that it is difficult to prepare appropriate amounts of
metaphases from cells with higher passages and cells
with more than 12 passages are not used for SCNT in
our lab we analyzed PFF26 and PEF0110 at passage 13.
In vitro development of SCNT embryos derived from
PKCs, PFFs, and PEFs
In 3 independent SCNT experiments PKCm, PFF26 and
PEF0110 were used as donor cells (Table 1). Fusion rate
and the proportion of development to blastocyst were
significant higher with PKCm as donor cells compared
to PEF0110. The cell numbers of blastocysts derived
from PKCm, PFF26 and PEF0110 donor cells corre-
sponded to 43.5±4.2, 56.1±9.5 and 23.5±7.5, respectively,
and were not significantly different.
Genetic modification of primary PKCs
Chemical transfection methods
Lipofection of PKC2109 resulted in transfection efficien-
cies of 24 to 52% using 0.5 μg pmaxGFPTM DNA, 0.5 to
1 μl Plus reagent and a lipid to DNA ratio of 2.5:1 or 3:1
(Table 2). Thereby, acceptable fluorescence intensities
(score: ++) were observed, although serious proportions
of detached cells indicated a high number of dead cells
(rating: 1 to 2) and the attached cells were strongly spin-
dle-shaped/partially enlarged and showed vacuoles/lipids
(rating: 3 to 5). In the control approach (0 μg DNA, 2.5×
lipid to DNA and 0.5 μl Plus reagent) cells had a good
quality (rating: 1 to 2) without vacuoles and no detached
cells (rating: 0; data not shown).
Figure 3 Growth potential of porcine kidney cells compared to fetal and ear fibroblasts. PKCm (A, left and middle panel) and PKC2109
(B, left and middle panel) grew rather in islands at P4 on non-coated plates compared to collagen-coated plates where they grew evenly spread.
Scale bar = 100 μm. The proliferation assay showed best growth potential on collagen-coated plates with PKCm (A, right diagram) and PKC2109
(B, right diagram). (C) Growth curves of PKCm, PKC2109, PFF26 and PEF0110. Every 12–24 h cell numbers of various cell types were determined.
The x-section (exponential growth phase) was used for calculation of population doubling time. PKC2109 and PKCm exhibited the shortest
population doubling time compared to PFF26 and PEF0110. (D) Correct karyotype (2n=38) of PKC2109 at passage 71.
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PKC2109 were obtained using 1 μg of DNA and 1.2, 3.2
or 4 μl of Nanofectin (Table 3). In these approaches, cell
quality (rating: 2) and the proportion of detached cells
(rating: 1) were acceptable, but the fluorescence intensity
was low when compared to lipofection (score: + to rarely
++). The control approaches (0 μg DNA, 3.2 μl Nanofec-
tin and 1 μg DNA, 0 μl Nanofectin, respectively)resulted in excellent to good cell quality (rating: 1) and
no cells in suspension (rating: 0, data not shown).
Physical transfection methods
To obtain optimal electroporation conditions for
PKC2109, different DNA concentrations (1, 5, 10, 20 μg
per 0.5×106 and 1×106 cells, respectively), resuspension
buffers (electroporation buffer from Bio-Rad, DMEM,







Reconstructed embryos developed to blastocyst stage (%) Cell number of blastocysts
[mean+/−SEM]hatched not hatched degen. overall
PKCm 85/90 81 10 6 1 17 (21.0)a 43.5±4.2
(94.4)a
PEF0110 70/85 70 2 1 0 3 (4.3)b 23.5±7.5
(82.4)b
PFF26 74/86 77 5 2 0 7 (9.1)a,b 56.1±9.5
(86.0)a,b
Analysis of blastocysts on day 7. Values with different superscript were significantly different (P<0.05), SEM = standard deviation. degen.=degenerated.
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http://www.biomedcentral.com/1472-6750/12/84PBS) and voltages (100 V or 230 V) were tested
(Table 4). The greatest transfection efficiencies (30 to
54%) were determined when using 0.5×106 cells (5 or
10 μg DNA) and 1×106 cells (10 or 20 μg DNA) at
230 V. Fluorescence intensity was very good, but a
high proportion of cells did not attach after electropor-
ation and indicated a high rate of cell loss during this
process (rating: 2). Attached cells showed signs of
stress including extreme spindle-shaped morphology
and vacuoles (rating: 3 to 5). The control experiment
(1×106 cells, 0 μg DNA, electroporation buffer)
resulted in stressed cells exhibiting large spindle-
shaped morphology (rating: 4), but a lower number of
cells did not attach (rating: 1; data not shown).
Optimal nucleofection parameters were ascertained in
initial experiments by testing various programs offered
by the supplier. Program U12 was the most efficient
resulting in 63% transfection efficiency, good fluores-
cence intensity (score: ++) and cells of good qualityTable 2 Lipofection results PKC2109
DNA amount [μg] Plus reagent [μl] Ratio lipid to DNA Quality









0.5 1.0 2.5:1 4
3.0:1 4




Scale for the assessment of cell quality: 1- excellent to good; 2- no vacuoles and lip
cells; 4- many vacuoles and lipids, stressed cells, partially enlarged cells; 5- a lot of l
assessment of cells in suspension: 0- none; 1- low number of cells; 2- a lot of cells;(rating: 1) using 0.5×106 cells of PKC2109, 2 μg DNA
and 5 different nucleofection programs (Table 5). There-
fore, U12 was used for further experiments using differ-
ent cell numbers and quantity of DNA. Best
transfection efficiency (89%), high fluorescence inten-
sity (score ++), low number of cells in suspension (rat-
ing: 1) and good quality of cell morphology (rating: 2)
was achieved using 0.5×106 cells and 20 μg DNA. The
control experiment (0.5×106 cells of PKC2109, 0 μg
DNA) resulted in best cell quality (rating: 1) and a low
number of cells in suspension (rating: 1; data not shown).
In PKCm, another primary kidney cell line, transfection
efficiencies between 49% and 66% and high fluores-
cence intensity (score: ++ to +++) were determined
using 0.5×106 cells and 2 μg DNA. Representative pic-
tures of nucleofected PKCs after using 2 μg DNA,
0.5×106 cells and U12 are shown in Figure 4.
After testing of 3 different nucleofection programs,
















ids detectable, cells are bit stretched; 3- partially vacuoles and lipids, stretched
arge vacuoles and lipids, altered morphology and enlarged cells; Scale for the
Fluor. = Fluorescence.
Table 3 Nanofection results PKC2109
DNA amount [μg] Nanofectin [μl] Quality Cells in suspension Fluor. intensity Transfection efficiency [%]
0.5 1.2 1 0 + 10
2.0 1 0 + 16
3.2 1 1 + 16
4.0 1 1 + 15
1.0 1.2 2 1 + 25
2.0 2 1 + 17
3.2 2 1 ++ 21
4.0 3 1 + 20
1.5 2.0 3 1 + 7
3.2 3 1 ++ 11
Scale for the assessment of cell quality: 1- excellent to good; 2- no vacuoles and lipids detectable, cells are bit stretched; 3- partially vacuoles and lipids, stretched
cells; Scale for the assessment of cells in suspension: 0- none; 1- low number of cells; 2- a lot of cells; Fluor. = Fluorescence.
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(rating: 1) and low number of cells in suspension
(rating: 1).
Transfection of the primary cell line PEF0110 using 3
different nucleofection programs resulted in poor trans-
fection efficiencies (11 to 34%) and low fluorescence
intensity (score: +).
Among the different transfection methods used for
transient transfection of PKC2109, nucleofection is the
most suitable, since it is highly efficient and results in
viable cells of good quality.
Generation of transgenic animals using PKCs as donor
cells
Additive gene transfer and re-cloning
For the generation of transgenic animals by additive
gene transfer (Figure 5A), resulting in random integra-
tion of a gene construct into the genome, wild-type cells
were transfected with a gene construct including the
gene of interest and a resistance gene for the generation
of stable transfected cell clones after antibiotic selection.
Since a mixed population of transfected and selected cell
clones was used for SCNT, the generated animals had to
be examined for transgenesis and expression level in theTable 4 Electroporation results PKC2109








Scale for the assessment of cell quality: 1- excellent to good; 2- cells are bit stretch
shaped morphology 5- extreme spindle-shaped cells with vacuoles; Scale for the as
cells; Fluor. = Fluorescence. Endotoxin-free purified DNA was used; Voltage: 230V.organs and tissues of interest. The best expressing animals
were used for breeding, for re-cloning or for a second
transfection with further gene constructs to generate
multi-transgenic animals.
In summary 7 different primary porcine kidney cell
populations, including PKCm and PKC2109, isolated
from neonatal to 13-month-old wild-type or trans-
genic pigs served as donor cells for SCNT after one
or two nucleofection rounds with 11 different gene
constructs [10]. In re-cloning experiments, 5 different
PKC lines isolated from neonatal to 13-month-old
cloned transgenic pigs without any further genetic
modification served as donor cells for SCNT [10].
Overall the litter rate and size were satisfying, where
38 embryo transfers after cloning of transfected cells
resulted in 22 litters (58%) with 83 animals and
35 embryo transfers after re-cloning gave rise to 16
litters (46%) with 48 piglets. Hence, different primary
kidney cells, including PKCm and PKC2109, were cap-
able of producing genetically modified pigs by additive
gene transfer. The efficiency in transgenic pig delivery
did not show significant differences between PKC2109,
PKCm and the fibroblasts examined (M. Kurome








ed/strongly fibroblast-like; 3- stretched cells with vacuoles; 4- very spindle-
sessment of cells in suspension: 0- none; 1- low number of cells; 2- a lot of
Table 5 Nucleofection results PKC2109, PKCm, PFF26 and PEF0110
Cell Number DNA amount [μg] Program Quality Cells in suspension Fluor. intensity Transfection efficiency [%]
PKC2109
0.5x106 2 A24 2 1 + 28
2 U23 2 2 + 60
2 U12 1 1 ++ 63
2 T16 2 1 + 54
2 V13 1 1 ++ 59
0.5x106 1 U12 1 1 + 36
5 U12 1 1 ++ 70
10 U12 1 1 +++ 77
20 U12 2 1 ++ 89
1.0x106 5 U12 1 1 ++ 68
10 U12 1 1 +++ 88
20 U12 2 2 +++ 83
PKCm
0.5x106 2 U12 1 1 ++ 49
2 T16 1 1 ++ 50
2 V13 2 1 +++ 66
PFF26
0.5x106 2 U12 1 1 + 53
2 T16 1 1 + 50
2 V13 2 2 ++ 77
PEF0110
0.5x106 2 U12 1 1 + 15
2 T16 1 1 + 11
2 V13 2 2 + 34
Scale for the assessment of cell quality: 1- excellent-good; 2- cells are bit stretched/strongly fibroblast-like; 3- stretched cells with vacuoles; 4- cells with very
spindle-shaped morphology 5- extreme spindle-shaped with vacuoles; Scale for the assessment of cells in suspension: 0- none; 1- low number of cells; 2- a lot of
cells; Fluor. = Fluorescence.
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In contrast to additive gene transfer, where pools of
stable transfected cell clones can be used for SCNT,
gene targeting requires clonal selection, which means
the generation of individual cell clones and their analysis
for homologous recombination. Figure 5B shows the se-
quential gene targeting of 2 alleles for the production of
a homozygous knockout pig. The PKCm line was used
for targeting of 3 different loci [8], using linearized
BAC-DNA. After a first round of transfection and selec-
tion, correctly targeted cell clones (1 allele) were used
for SCNT. In summary, 19 ETs resulted in 7 litters
(37%) with a total of 28 animals (including 1 stillborn)
and 2 interrupted pregnancies (day 58 and 61) contain-
ing 17 fetuses. PKCs from heterozygous animals were
used for targeting of the second allele of the locus. After
transfer of embryos to 4 recipients 2 litters (50%) with
11 offspring (including 2 stillborn) were obtained. Thus,
SCNT using targeted PKCm clones resulted in accept-
able pregnancy rates and litter sizes.Discussion
Various types of primary transgenic or non-transgenic
porcine cells were used as nuclear donors for the pro-
duction of cloned embryos or piglets, but the
characterization of the cells is normally restricted to the
efficiency of transgenic animal production. Nonetheless,
a comprehensive analysis of defined cell lines might fa-
cilitate choosing appropriate cell types for advanced
transgenic strategies and improve the use of primary
cells for the production of large animal models. We used
two different primary kidney cell lines and compared
them with fetal or ear fibroblasts and observed that sub-
clones of these cells differ in morphology and growth
potential. Various groups verified different types of fibro-
blasts (cortical and inner medullary fibroblasts) and
other cell types such as dendritic cells, macrophages and
lymphocyte-like cells in kidney cell cultures (reviewed in
[26,27]). In our hands, the diversity of cell morphologies
decreased over several passages in all investigated cell
lines, probably due to the culture conditions promoting
Figure 4 Transiently nucleofected porcine kidney cells. PKCm (A) and PKC2109 (B) 24 h after nucleofection with a GFP expressing plasmid
using 0.5×106 cells and 2 μg DNA at passage 4. Scale bar = 100 μm.
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lifespan of cultured cell types. Regarding the growth po-
tential, PKCs grew faster than fetal or ear fibroblasts, al-
though the kidney cells were isolated from 3-month-old
animals, whereas PFF originated from a fetus and the PEF
from a neonatal ear. The diversity of cell types in PKCs
might influence the growth of cell population in a positive
way due to factors which are produced by neighboring
cells, e.g. the extracellular matrix produced by renal fibro-
blasts [26]. However, we showed that all investigated cells,
including the kidney cells, grew better on coated com-
pared to non-coated plates. It has already been shown that
collagen type I, which is part of the extracellular matrix, is
a prevalent substrate for the culture of several cell types,
including human skin fibroblasts [28] and PFFs [7].
Various methods have successfully been used to intro-
duce exogenous DNA into porcine fibroblasts. During
chemical transfection, we suggest that the vesicles were
formed of big DNA-lipid conglomerates and the vacuoles
probably originate from cell stress during transfection.
Overall, our lipofection results are very heterogeneous
due to the numerous parameter combinations (ratio of
DNA to lipid, amount of DNA, Plus-reagent and lipofec-
tion solution) which had to be tested. The tested chemical
transfection methods and in addition the conventional
electroporation were not suitable for efficient transfection
either due to low transfection efficiencies, formation of
vacuoles and lipids or high toxicity.
Nucleofection has been used for transfection of vari-
ous cells [23,29]. We achieved best results by nucleofec-
tion of PKCs with 70% to 89% transfection efficiency,which is comparable to the efficiency of 90% in PFFs
[30]. In general, after nucleofection of all primary cell
lines (PKC, PFF and PEF) we observed low cytotoxicity
and only marginal changes of cell morphology. This con-
firms partly previous studies using the nucleofection
technology, showing no effects on cell properties, such
as alteration of cell morphology, response to chemicals
and pattern of gene expression [31,32].
Using PKCs as donor cells for SCNT, the obtained
blastocyst rate of 21% was higher in comparison to other
reports showing a blastocyst rate of 4 to 14.8% after
6–7 days [17,18] of embryo in vitro culture. The SCNT
with PFFs as donor cells resulted in a blastocyst rate of
9.1%. In other studies the blastocyst rate using PFFs ran-
ged from 11.9 to 31.2% [12,16,33,34], which is several
times higher compared to our blastocyst rate. Neverthe-
less, it is difficult to compare cloning efficiencies between
different laboratories, because a plethora of parameters
influences the outcome of SCNT experiments. Even cell
cultures from the same fetus may differ in their develop-
ment capability of embryos after SCNT [35,36]. More-
over, the blastocyst rate is not compulsory meaningful
for in vivo developmental competence, it rather gives a
rough estimation of the principle applicability of a
defined primary cell line as a donor for SCNT.
In the last years, the generation of cloned transgenic
pigs using nucleofected fibroblasts from fetal or ear tis-
sue was quite successful in our lab [9,10,37]. The usage
PKCs for SCNT after transfection and for re-cloning
[10] was in our hands satisfying and comparable to PFF,
whereas it has to be kept in mind that different gene
Figure 5 Generation of transgenic pigs by additive gene transfer and gene targeting combined with SCNT. (A) Additive gene transfer.
Cells are transfected with a vector containing the gene of interest (GOI) and a resistance gene. After antibiotic selection the single cell clones are
mixed and transferred to an enucleated oocyte (SCNT) followed by an embryo transfer (ET) to synchronized gilts. After genotyping and gene
expressing analysis of the born pigs the best expressing animal is re-cloned or used for a second round of transfection. (B) Gene targeting. In the
first targeting round the cells are transfected with a targeting vector containing beside homologous regions of the target locus, a resistance gene
(RG1). After selection and characterization of the generated single cell clones, heterozygous knockout cells are used for SCNT followed by the ET.
For the targeting of the second allele cells isolated of the heterozygous knockout animals are used for a second round of transfection, using a
second targeting vector with another resistance gene (RG2). All following procedures resemble the first round.
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http://www.biomedcentral.com/1472-6750/12/84constructs were used. Furthermore, we were able to tar-
get successfully 3 different loci in PKCs by homologous
recombination [8] and SCNT with several of these cor-
rectly targeted cell clones resulted in litter rates of 37
to 50%. Rogers et al. [7] verified that homologous re-
combination depends on donor cells, because they
achieved targeting frequencies between 0.07 to 10.93%
using various primary PFF cultures prepared from dif-
ferent fetuses, but from same uterus at the same time
[7]. This underlines the importance of characterization
of donor cell cultures provided for genetic modifica-
tion and SCNT.
Beside the easy isolation procedure and good prolifera-
tion capacity of kidney cells it has to be mentioned that
for the generation of multi-transgenic pigs and re-cloning
kidney cells can be isolated after killing the animals for
gene expression analysis anyway or from a biopsy taken
from the living animal.
Conclusion
Our porcine kidney cells are probably a mixture of dif-
ferent cell types showing better proliferation rate, growth
capacity, transfection efficiency and blastocyst rate after
SCNT compared to PFFs and PEFs. There is no evidence
that this mixed population has a negative influence on
transfection and further procedures which are necessary
for transgenic pig production. Primary porcine kidney
cells are highly suitable for additive gene transfer and
gene targeting, and subsequent production of genetically
modified pigs by SCNT. It has to be kept in mind that
each primary cell culture originates from a different
animal and preparation, and might show different
properties. However, our dataset includes kidney cells
from different animals and preparations all showing
the same basic characteristics.
Methods
Animal care
All animal procedures in this study were performed
according to the German Animal Welfare Act and to a
protocol approved by the Regierung von Oberbayern.
Cell culture
Porcine fetal fibroblasts (PFFs), porcine ear fibroblasts
(PEFs) and porcine kidney cells (PKCs) were principally
cultured as mentioned below unless not otherwise noted.
Cells were grown on collagen type 1-coated (Serva Elec-
trophoresis, Heidelberg, Germany) cell culture dishes, in
medium containing Dulbecco’s modified Eagle medium
(DMEM; Invitrogen, Darmstadt, Germany) supplemen-
ted with 293 mg/l L-glutamine, 100 units/ml penicillin,
100 μg/ml streptomycin (PAA, Pasching, Austria),
0.1 mM 2-mercaptoethanol (Sigma-Aldrich, Steinheim,
Germany), 1% (v/v) nonessential amino acid and 1%(v/v) sodium pyruvate (Invitrogen) and different amounts
of fetal calf serum (FCS; Invitrogen) depending on the pri-
mary cell line (PKC 10%, PFF and PEF 15% (v/v)). The
cells were cultured at 37°C in a humid atmosphere of 5%
CO2 in air. PFF and PEF were harvested using 0.1% tryp-
sin (DifcoTM, Becton Dickinson, Heidelberg, Germany)/
0.008% EDTA (Sigma-Aldrich) solution and PKC were
harvested with 0.4% trypsin/0.032% EDTA. The split ratio
of the cells was between 1:2 and 1:4 depending on conflu-
ence and growth potential of the cells.
Cell isolation
After slaughter the kidney (for PKCs) or the uterus
containing the fetus (for PFFs) were excised surgically.
The ear tissue (for PEFs) was obtained from a living
animal by cutting a piece from the ear using a pincer.
In general, tissue pieces were stored in washing buffer
(PBS with 1-2% (v/v) Pen/Strep and 1-2% (v/v) Ampho-
tericin B (PAA)) in the refrigerator or on ice until isola-
tion. The isolation of the primary cell lines PKC2109
from a 3-month-old male pig and PEF0110 form a neo-
natal female piglet was conducted by the same way.
Pieces taken from the cortex and medulla of the kidney
(2×1×1 cm) and from the ear (0.5×0.5 cm) were washed
twice in washing buffer, minced and washed with
DMEM by centrifugation (5–10 min; 180×g) until the
supernatant became clear. Subsequently, the pelleted
tissue pieces were resuspended in 15 ml Hank’s Buffered
Salt Solution (HBSS; PAA) with 0.1 % (w/v) collagenase
II (Invitrogen) and incubated at 37°C while stirring for
1 to 1.5 h (kidney) or 2 h (ear). After incubation,
flasks were filled up to 50 ml with DMEM, filtered
through a 100-μm mesh and washed with DMEM
(5–10 min, 180×g) until the supernatant became clear.
Depending on pellet size 1/6 to 1/24 of the resus-
pended PKCs were seeded per 100 mm plate and all
resuspended PEFs onto a 60 mm plate. The isolation
of the primary cell line PKCm from the kidney (cortex
and medulla) of a 3-month-old male pig was basically
the same with the following modifications. The collage-
nase digestion was done at 37°C with shaking every 15
min, and after digestion the remaining tissue pieces were
further treated using 0.25% trypsin/0.02% EDTA for 15
min at 37°C.
For the isolation of PFF26, the backbone of a 27-day-old
male fetus was prepared by removing head, legs and in-
ternal organs and washed 3 times in PBS containing 1×
Pen/Strep, minced and washed twice in DMEM. Tissue
was resuspended and incubated in EGTA buffer [38] ro-
tating in front of an infrared lamp at 37°C for 33 min.
Afterwards, tissue pieces were centrifuged, resuspended in
DMEM containing 1 mg/ml (m/v) collagenase II and
1 mg/ml hyaluronidase and incubated for 20 min at 37°C.
After washing by centrifugation, tissue pieces were
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digested for 40 min at 37°C. Afterwards, the cells were
washed by centrifugation, resuspended in DMEM, filtered
through a tea strainer and washed twice in DMEM. The
whole cell pellet was resuspended in culture medium and
seeded onto a 100 mm petri dish.
Chromosome preparation
The metaphase spreads were prepared according to stand-
ard protocols [39]. In brief, the cells were harvested with a
confluence of 60-90%, incubated with Colcemide (Invitro-
gen) (10 μg/ml) for 1 h at 37°C, followed by hypotonic
treatment (75 mM KCl) for 15 min at 37°C, fixed and
washed 3 times with ice-cold fixative (75% methanol, 25%
glacial acetic acid). Then, cell suspension was dropped onto
45°C preheated glass slide, dried and chromosomes were
mounted with Vectashield antifade solution containing
4’,6’-diamidino-2-phenylindole (DAPI; Vector Laboratories,
Burlingame, CA, USA) for counterstaining. Metaphases
were analyzed using an inverted epifluorescence micro-
scope (Axiovert 200M; Zeiss, Germany). Chromosomes
were counted using the ImageJ software.
Growth curve
5.5×104 cells of the primary cell lines PKCm, PFF26,
PEF0110 were plated onto 12-well plates and cultured
under standard conditions. Over a period of 5 days, 3
wells of each culture were trypsinized and counted every
12 h. Population doubling was calculated by the follow-
ing formula using the time between the 2 measurement
points of 36 h and 60 h:
log counted cell numberð Þ–log starting cell numberð Þ½ 
log 2ð Þ
Cell proliferation assay
Different cell numbers (2,000, 5,000, or 10,000) of
PKC2109 and PKCm were seeded in duplicates onto 96-
well plates 48 h before treatment with MTT. To obtain
a standard curve with defined cell numbers, seven meas-
uring points in duplicates were applied: 250–50000 cells
per well (PKC2109) and 2500–50000 cells per well
(PKCm). The cells were seeded onto the plate 4 h before
the MTT treatment started, so that they had attached
before treatment started. 10 μl of MTT (0.5 mg/ml) of
the MTT-Cell Proliferation Kit I (Roche Diagnostics,
Basel, Switzerland) were added to each well containing
100 μl culture medium and plates were incubated in the
incubator for 4 h. After this, 100 μl of the solubilisation
solution was added to each well and incubated in the in-
cubator overnight to make the conversion of MTT vis-
ible. The formation of formazan crystals was measured
by spectrophotometrical absorbance of the sample usingSunriseTM microplate reader (Tecan Austria GmbH,
Salzburg, Austria) at a wavelength of 562 nm. Analysis
of data was processed with the Magellan Software.
Cell transfection
For chemical transfections, 3.2×104 of PKC2109 were
seeded in 500 μl per well onto a 24-well plate the day
before transfection. The cells were transfected with the
GFP expressing plasmid pmaxGFPTM (Lonza, Cologne,
Germany) to determine the transfection efficiency. The
medium was changed on the day after transfection. For
evaluation of the transfection process different para-
meters were assessed 24 h after transfection (see legend
of Tables 2, 3, 4, 5): the morphology and cell quality (rat-
ing: 1 to 5), the amount of cells in suspension, probably
being dead cells (rating: 0 to 2) and the fluorescence
intensity (score system: lowest [−] to highest [+++]).
Nanofection
The Nanofectin Kit (PAA) was used according to manu-
facturer’s instructions. 0.5 or 1.0 μg DNA was added
each to 1.2, 2, 3.2 or 4 μl Nanofection solution whereas
1.5 μg DNA was added to 2 or 3.2 μl Nanofectin
solution.
Lipofection
The Lipofectamin LTX + Plus Reagents Kit (Invitrogen)
was used according to manufacturer’s instructions. 0.25,
0.5 or 0.75 μg of DNA was diluted in DMEM (5, 10 or
15 ng/μl DNA) and mixed thoroughly. The optimized
volume of the Plus reagent (0.25, 0.5, 0.75 or 1 μl) was
added to the diluted DNA. Lipofectamin LTX was added
in different ratios (1:1 – 1:4) to the diluted DNA/Plus
solution.
For physical transfection, cells were splitted 1 day be-
fore the experiment. Prior transfection cells were washed
twice with PBS, trypsinized and counted. Then, 0.5 and
1×106 cells were centrifuged (5 min, 180×g), resuspended
in the respective solution and transfected either with
pmaxGFPTM or endotoxin-free purified pmaxGFPTM.
After transfection, cells were seeded onto 35 mm or
60 mm petri dishes (depending on cell number) contain-
ing pre-warmed 15% FCS culture medium.
Electroporation
For electroporation, cell pellets of PKC2109 were
washed twice with PBS and resuspended in 600 μl of
either Gene Pulser TM electroporation buffer (Bio-Rad,
Munich, Germany), PBS or DMEM. DNA (1, 5, 10 or
20 μg) was added to the cell suspension and transferred into
a 4 mm gap electroporation cuvette (Bio-Rad). Cells were
electroporated with Gene Pulser II (Bio-Rad) using various
settings (Voltage: 100 V, 230 V; High Capacity 500 μF).
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For nucleofection of the cell lines PKCm, PKC2109,
PEF0110 and PFF26 the NucleofectorTMII device (Lonza,
Cologne, Germany) and the AmaxaTM Basic Nucleofec-
torTM Kit Primary Fibroblasts (Lonza) were used. 0.5 or
1×106 cells were mixed with 1, 2, 5, 10 or 20 μg of plasmid
DNA and 100 μl Nucleofector solution and nucleofected
according to manufacturer’s instructions with the recom-
mended Nucleofector programs A24, T16, U12, U23
and V13.
If not stated otherwise, transfection efficiency was
determined 24 h after transfection as the [(No. of GFP
positive cells) / (No. of DAPI positive cells)] × 100.
Therefore, 24 h after transfection, cells were washed
twice with PBS and fixated with 4% (m/v) paraformalde-
hyde (Merck, Darmstadt, Germany) for 20 min at RT in
the dark. After fixation, cells were washed with PBS and
incubated with DAPI-Methanol (1 μg/ml) for 10 min at
37°C. Subsequently, cells were washed with methanol
and PBS. Finally, the fixed cells were covered with PBS
and analyzed using an inverted epifluorescence micro-
scope (Axiovert 200M; Zeiss, Germany) equipped with
an appropriate filter set.Additive gene transfer
Various cell lines of PKC, PFF and PEF were genetically
modified by nucleofection using the AmaxaTM Basic
NucleofectorTM Kit Primary Fibroblasts and the Nucleo-
fector IIW device (Lonza). 0.5×106 to 1×106 cells were
transfected with 1–3 μg endotoxin-free purified and line-
arized conventional plasmids of 1.6 to 11.1 kb length and
BAC vectors of >150 kb length. After transfection, cells
were plated either onto 35 mm or 60 mm petri dish
depending on cell number using 15% FCS in DMEM cul-
ture medium. After 24–48 h, selection was started with
the following antibiotic concentrations: PKC – 10 μg/μl
blasticidin S (PAA), 1.2 mg/ml G418 (Invitrogen) or 3 μg/
ml puromycin (PAA); PEF – 4 μg/μl blasticidin S; PFF –
0.4 or 0.6 mg/ml G418. Selection was conducted for 7–10
days, including regular change of medium and 1 passaging
step [10].Gene targeting
Endotoxin-free purified BAC vectors of >150 kb size
were linearized and nucleofected into 0.5×106 or 1×106
PKC. 24–72 h after nucleofection the cells were counted
and seeded onto 96-well plates for selection with
1.2 mg/ml G418 or 6 μg/ml blasticidin S in 15% DMEM
culture medium for 7 days. Then, 96-well plates were
screened for single cell colonies, which were splitted for
DNA isolation and SCNT [10].Somatic cell nuclear transfer and embryo transfer
In general, 48 h prior to SCNT cells were cultured in
starvation medium containing all components of the
normal culture medium, but only 0.5% FCS. Nuclear
transfer was performed as described by Kurome et al.
[40] and Klymiuk et al. [10]. The generated embryos
were transferred into estrus synchronized gilts (ET), as
published before [41], on the same day of nuclear trans-
fer or 1–2 days later. Gilts were checked regularly after
ET by ultrasonic examination for conception and moni-
toring of pregnancy.
For determination of the competence of cloned
embryos in vitro PKCm, PFF26 and PEF0110 were used
as donor cells at passage 4 and transferred to enucleated
oocytes. After electric fusion and activation of the result-
ing embryos, they were cultured in porcine zygote
medium (PZM5) [42] for 7 days. Then, the quality of the
embryos was evaluated, they were fixed with acetic acid
and methanol (1:3), nuclei of embryos were stained with
1% orcein (Sigma) and counted thereafter.
Statistical analysis
χ2-test was used to compare the rate of embryo develop-
ment. The mean cell number of the embryos was compared
using Student’s t-test.
Additional file
Additional file 1: Single cell clone colonies of PKC2109 at P3. Single
cell colonies were generated and analyzed after 5–8 days. The cells
and formed colonies differed morphologically: fibroblast-like cells [A, B, C,
D, F], epithelial- and endothelial-like cells [E], cell size (smaller [A]), colony
compactness (cells very close [A, C, E, F], gaps between cells [B, D])
and colony shape (clearly defined [A, C], frayed colonies [B, D, F]).
Scale bar = 100 μm.
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